3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Advanced Gastric Cancer
2
Thoracic Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Osteosarcoma
1
Neoplasms by Site
1
Mouth Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Liver Diseases
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gestational Trophoblastic Disease
1
Gastrointestinal Neoplasms
1
Interventions
Psychiatric Rehabilitation
2
Methylprednisolone
2
Immunologic Techniques
2
Flow Cytometry
2
Filgrastim
2
Alemtuzumab
2
sargramostim
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
camrelizumab
1
apatinib
1
aldesleukin
1
Thrombopoietin
1
Tacrolimus
1
Surveys and Questionnaires
1
Quality of Life
1
Prednisone
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Methods
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Interferon-alpha
1
Immunotherapy
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Granisetron
1
Gene Expression Profiling
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gestational Trophoblastic Disease
×
camrelizumab
×
Clear all
NCT04047017
2021-07-30
GTN
Peking Union Medical College Hospital
Phase 2
Completed
20 enrolled